Inotiv, Inc. (NOTV)
Largest Insider Buys in Sector
NOTV Stock Price History Chart
NOTV Stock Performance
About Inotiv, Inc.
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Insider Activity of Inotiv, Inc.
Over the last 12 months, insiders at Inotiv, Inc. have bought $163,981 and sold $0 worth of Inotiv, Inc. stock.
On average, over the past 5 years, insiders at Inotiv, Inc. have bought $215,580 and sold $95,143 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Beattie John Gregory (Chief Operating Officer) — $149,836. Garrett Michael (Chief Commercial Officer) — $14,145.
The last purchase of 47,966 shares for transaction amount of $149,836 was made by Beattie John Gregory (Chief Operating Officer) on 2023‑12‑14.
List of Insider Buy and Sell Transactions, Inotiv, Inc.
| 2023-12-14 | Beattie John Gregory | Chief Operating Officer | 47,966 0.1875% | $3.12 | $149,836 | +30.11% | ||
| 2023-12-14 | Garrett Michael | Chief Commercial Officer | 5,000 0.0177% | $2.83 | $14,145 | +30.11% | ||
| 2023-03-14 | Sagartz John E | Chief Strategy Officer | 5,100 0.0207% | $4.91 | $25,041 | -12.26% | ||
| 2023-02-22 | Beattie John Gregory | Chief Operating Officer | 5,000 0.0188% | $6.99 | $34,950 | -42.90% | ||
| 2022-12-09 | Sale | Pitchford William D | Chief Human Resources Officer | 2,123 0.0085% | $5.82 | $12,366 | -13.38% | |
| 2022-12-01 | Sale | Neff R Matthew | director | 1,000 0.0042% | $6.12 | $6,120 | -13.42% | |
| 2022-11-01 | Sale | Neff R Matthew | director | 1,000 0.004% | $21.12 | $21,123 | -74.83% | |
| 2022-10-17 | Sale | Neff R Matthew | director | 1,000 0.0038% | $19.10 | $19,100 | -72.52% | |
| 2022-03-15 | Harkness James | Chief Operating Officer, RMS | 4,049 0.0148% | $18.84 | $76,283 | -22.37% | ||
| 2021-12-22 | Sale | Downing Philip A | Sr. VP, Preclinical Srvcs. | 3,057 0.0141% | $43.04 | $131,577 | -56.03% | |
| 2021-02-24 | Leasure Robert Jr. | President and CEO | 5,000 0.0442% | $14.42 | $72,100 | +96.38% | ||
| 2021-02-23 | Beattie John Gregory | Chief Operating Officer | 8,288 0.0719% | $14.00 | $116,032 | +98.69% | ||
| 2020-08-19 | Sagartz John E | Chief Strategy Officer | 3,733 0.0349% | $4.75 | $17,732 | +229.17% | ||
| 2020-08-19 | Neff R Matthew | director | 5,000 0.0468% | $4.75 | $23,750 | +229.17% | ||
| 2020-06-15 | Leasure Robert Jr. | President and CEO | 2,884 0.0258% | $5.20 | $14,997 | +36.21% | ||
| 2020-05-21 | Pitchford William D | Chief HR Officer | 10,000 0.0881% | $4.47 | $44,700 | +31.83% | ||
| 2020-05-21 | Taylor Beth | VP- Finance & CFO | 3,300 0.0294% | $4.52 | $14,916 | +31.83% | ||
| 2020-05-20 | Taylor Beth | VP- Finance & CFO | 4,933 0.0445% | $4.42 | $21,804 | +35.19% | ||
| 2020-05-19 | Taylor Beth | VP- Finance & CFO | 5,067 0.0447% | $4.38 | $22,193 | +32.53% | ||
| 2020-03-16 | Leasure Robert Jr. | 5,700 0.0526% | $3.49 | $19,893 | +47.71% |
Insider Historical Profitability
| Beattie John Gregory | Chief Operating Officer | 111761 0.4333% | $1.69 | 3 | 0 | +27.9% |
| Garrett Michael | Chief Commercial Officer | 16467 0.0638% | $1.69 | 1 | 0 | |
| Sagartz John E | Chief Strategy Officer | 692047 2.6833% | $1.69 | 3 | 0 | +99.88% |
| Pitchford William D | Chief Human Resources Officer | 74051 0.2871% | $1.69 | 2 | 1 | +31.83% |
| Neff R Matthew | director | 62388 0.2419% | $1.69 | 6 | 3 | +72.01% |
| Oakley Daniel Thomas | 48546 0.1882% | $1.69 | 10 | 0 | +81.93% | |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 40195 0.1559% | $1.69 | 1 | 1 | +112.24% |
| Harkness James | Chief Operating Officer, RMS | 38968 0.1511% | $1.69 | 1 | 0 | <0.0001% |
| Johnson Richard Allen | 30000 0.1163% | $1.69 | 1 | 0 | <0.0001% | |
| Davis Gregory Cole | 20000 0.0775% | $1.69 | 3 | 0 | ||
| Taylor Beth | VP- Finance & CFO | 13300 0.0516% | $1.69 | 3 | 0 | +33.18% |
| Perrow Wendy | 10000 0.0388% | $1.69 | 1 | 0 | +32.4% | |
| Leasure Robert Jr. | President and CEO | 5000 0.0194% | $1.69 | 15 | 0 | +77.97% |
| Blumhoff Jill | 1811 0.007% | $1.69 | 1 | 0 |
Institutional Investor Ownership
| The Vanguard Group | $11.42M | 4.02 | 1.04M | +0.98% | +$110,997.25 | <0.0001 | |
| Millennium Management LLC | $5.29M | 1.86 | 483,796 | +91.3% | +$2.53M | <0.01 | |
| Ameriprise Financial | $4.91M | 1.73 | 449,159 | +301.54% | +$3.69M | <0.01 | |
| Goldman Sachs | $2.45M | 0.86 | 223,730 | +546.86% | +$2.07M | <0.0001 | |
| Geode Capital Management | $2.39M | 0.84 | 218,230 | +13.49% | +$283,774.73 | <0.0001 | |
| Two Sigma | $2.38M | 0.84 | 217,960 | +298.78% | +$1.79M | <0.01 | |
| BlackRock | $2.33M | 0.82 | 212,786 | -1.55% | -$36,659.94 | <0.0001 | |
| Man Group Plc | $2.22M | 0.78 | 203,344 | +1,540.66% | +$2.09M | 0.01 | |
| Marshall Wace | $1.68M | 0.59 | 153,381 | +70.14% | +$691,779.90 | <0.01 | |
| D. E. Shaw & Co. | $1.62M | 0.57 | 148,111 | New | +$1.62M | <0.01 | |
| Oak Family Advisors Llc | $1.6M | 0.56 | 146,428 | 0% | +$0 | 0.62 | |
| Rice Hall James & Associates, LLC | $1.56M | 0.55 | 142,484 | +1.23% | +$18,980.90 | 0.09 | |
| American Century Investments | $1.54M | 0.54 | 141,048 | +833.6% | +$1.38M | <0.01 | |
| Formula Growth Ltd | $1.54M | 0.54 | 141,000 | New | +$1.54M | 0.49 | |
| Renaissance Technologies | $1.38M | 0.49 | 126,364 | +166.23% | +$862,902.41 | <0.01 | |
| BNY Mellon | $1.27M | 0.45 | 116,040 | +1,020.18% | +$1.16M | <0.0001 | |
| Qube Research & Technologies | $1.22M | 0.43 | 111,639 | +69,240.99% | +$1.22M | <0.01 | |
| Luther King Capital Management | $1.08M | 0.38 | 98,600 | 0% | +$0 | 0.01 | |
| Mariner Llc | $1.02M | 0.36 | 93,316 | +0.86% | +$8,752.00 | <0.01 | |
| Squarepoint Ops LLC | $968,912.00 | 0.34 | 88,566 | -4.43% | -$44,864.94 | <0.01 | |
| Two Sigma Advisers LP | $949,592.00 | 0.33 | 86,800 | +264.71% | +$689,220.00 | <0.01 | |
| Jane Street Capital | $935,665.00 | 0.33 | 85,527 | +168.33% | +$586,963.58 | <0.01 | |
| Citadel Advisors LLC | $923,227.00 | 0.33 | 84,390 | +211.23% | +$626,588.77 | <0.01 | |
| Hrt Financial Llc | $888,000.00 | 0.31 | 81,238 | New | +$888,000.00 | 0.01 | |
| Wynnefield Capital, Inc. | $877,989.00 | 0.31 | 80,255 | -46.5% | -$763,009.69 | 0.35 | |
| Citigroup | $854,929.00 | 0.3 | 78,147 | +781,370% | +$854,819.60 | <0.01 | |
| Susquehanna International Group | $809,604.00 | 0.29 | 74,004 | +90.71% | +$385,088.11 | <0.01 | |
| Eam Investors | $789,890.00 | 0.28 | 72,202 | New | +$789,890.00 | 0.12 | |
| Balyasny Asset Management Llc | $768,108.00 | 0.27 | 70,211 | -92.8% | -$9.9M | <0.01 | |
| JPMorgan Chase | $751,184.00 | 0.26 | 68,664 | +29,118.72% | +$748,613.10 | <0.0001 | |
| State Street | $744,237.00 | 0.26 | 68,029 | -2.3% | -$17,503.99 | <0.0001 | |
| Invesco | $660,327.00 | 0.23 | 60,359 | New | +$660,327.00 | <0.0001 | |
| ROYCE & ASSOCIATES INC | $555,391.00 | 0.2 | 50,767 | New | +$555,391.00 | 0.01 | |
| Fi3 Financial Advisors, LLC | $204,661.00 | 0.19 | 47,930 | 0% | +$0 | 0.09 | |
| Blue Edge Capital LLC | $459,480.00 | 0.16 | 42,000 | New | +$459,480.00 | 0.08 | |
| Northern Trust | $440,521.00 | 0.16 | 40,267 | +22.34% | +$80,430.88 | <0.0001 | |
| Kennedy Capital Management Inc | $433,563.00 | 0.15 | 39,631 | +6.38% | +$26,004.37 | 0.01 | |
| Point72 Asia Singapore Pte Ltd | $416,737.00 | 0.15 | 38,093 | +4,661.63% | +$407,985.01 | 0.04 | |
| Morgan Stanley | $396,783.00 | 0.14 | 36,269 | +1,101.76% | +$363,766.07 | <0.0001 | |
| Walleye Capital | $360,331.00 | 0.13 | 32,937 | New | +$360,331.00 | <0.01 | |
| Monument Capital Management | $354,686.00 | 0.13 | 32,421 | -1.42% | -$5,098.04 | 0.11 | |
| Cubist Systematic Strategies | $349,938.00 | 0.12 | 31,987 | +213.84% | +$238,437.45 | <0.01 | |
| Dimensional Fund Advisors | $331,799.00 | 0.12 | 30,329 | 0% | +$0 | <0.0001 | |
| Marathon Trading Investment Management Llc | $317,260.00 | 0.11 | 29,000 | New | +$317,260.00 | 0.12 | |
| Virtu Financial Llc | $300,000.00 | 0.11 | 27,378 | New | +$300,000.00 | 0.03 | |
| Denali Advisors | $276,782.00 | 0.1 | 25,300 | New | +$276,782.00 | 0.08 | |
| ExodusPoint Capital Management, LP | $267,000.00 | 0.09 | 24,412 | New | +$267,000.00 | <0.01 | |
| LAZARD ASSET MANAGEMENT LLC | $266,000.00 | 0.09 | 24,392 | New | +$266,000.00 | <0.0001 | |
| Bank of America | $255,766.00 | 0.09 | 23,379 | +51.03% | +$86,414.97 | <0.0001 | |
| Just Invest, LLC | $233,099.00 | 0.08 | 21,307 | +0.95% | +$2,188.00 | 0.01 |